Willimann P, Alig A, Binswanger U
Nephron. 1979;23(4):191-93. doi: 10.1159/000181633.
Minimal dose heparinization inhibiting clotting factor IXa, Xa, XIa, as monitored by the activated partial thromboplastin time, was compared with conventional intermittent, continuous and regional heparinization during hemodialysis treatment. Blood loss in coil dialyzers was the same. Heparin dosage was reduced markedly. Protamine sulfate and infusion equipment were not required. No bleeding problems were encountered in high-risk patients.
通过活化部分凝血活酶时间监测,比较了抑制凝血因子IXa、Xa、XIa的最小剂量肝素化与血液透析治疗期间传统间歇性、持续性和区域性肝素化的效果。盘管式透析器的失血量相同。肝素剂量显著降低。无需硫酸鱼精蛋白和输注设备。高危患者未出现出血问题。